fluorodeoxyglucose f18 has been researched along with vorinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bots, M; Cullinane, C; Martin, BP; Newbold, A | 1 |
| Chan, PC; Chang, CA; Chang, CW; Chen, FD; Chiou, SH; Chou, LS; Ho, CH; Hwang, JJ; Lin, WJ; Liu, RS; Wang, HE; Wu, CY | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and vorinostat
| Article | Year |
|---|---|
Fluorodeoxyglucose-based positron emission tomography imaging to monitor drug responses in hematological tumors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Hydroxamic Acids; Lymphoma, B-Cell; Mice; Mice, Inbred C57BL; Positron-Emission Tomography; Vorinostat; Xenograft Model Antitumor Assays | 2014 |
Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET.
Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cell Survival; Disease Models, Animal; Fluorodeoxyglucose F18; Hep G2 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunohistochemistry; Liver Neoplasms; Male; Mice; Neoplasm Transplantation; Positron-Emission Tomography; Vorinostat | 2015 |